D.E. Shaw & Co’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.79M | Buy |
|
|||||
|
2025
Q4 | $101K | Buy |
|
|||||
|
2025
Q3 | $26.3K | Sell |
|
|||||
|
2025
Q2 | $128K | Buy |
|
|||||
|
2025
Q1 | $127K | Buy |
|
|||||
|
2024
Q4 | $275K | Sell |
|
|||||
|
2024
Q3 | $678K | Sell |
|
|||||
|
2024
Q2 | $1.65M | Sell |
|
|||||
|
2024
Q1 | $4.06M | Buy |
|
|||||
|
2023
Q4 | $1.38M | Sell |
|
|||||
|
2023
Q3 | $807K | Sell |
|
|||||
|
2023
Q2 | $1.43M | Buy |
|
|||||
|
2023
Q1 | $610K | Buy |
|
|||||
|
2022
Q4 | $507K | Sell |
|
|||||
|
2022
Q3 | $1.14M | Buy |
|
|||||
|
2022
Q2 | $594K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $829K | Buy |
|
|||||
|
2021
Q3 | $442K | Sell |
|
|||||
|
2021
Q2 | $626K | Buy |
|
|||||
|
2021
Q1 | $201K | Sell |
|
|||||
|
2020
Q4 | $417K | Buy |
|